EIKN Earnings — Eikon Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
EIKN — Eikon Therapeutics, Inc. Common Stock
XNAS
Price$10.98
Market Cap$594.7M
P/E—
52W Range$7.90 – $17.40
Next Earnings2026-11-06
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
